CXCR2 and neoplasm: This translational study demonstrates the relationship between peripheral and intratumour granulocytic myeloid compartments in patients with mCRPC, and indicates that a tumour-elicited and senescence-associated secretome drives CXCR2-expressing myeloid cell chemotaxis into tumour to fuel disease progression and treatment resistance.